On-going clinical trials for elderly patients with a hematological malignancy: are we addressing the right end points?

@article{Hamaker2014OngoingCT,
  title={On-going clinical trials for elderly patients with a hematological malignancy: are we addressing the right end points?},
  author={M E Hamaker and Reinhard Stauder and Barbara C van Munster},
  journal={Annals of oncology : official journal of the European Society for Medical Oncology},
  year={2014},
  volume={25 3},
  pages={675-81}
}
BACKGROUND Cancer societies and research cooperative groups worldwide have urged for the development of cancer trials that will address those outcome measures that are most relevant to older patients. We set out to determine the characteristics and study objectives of current clinical trials in hematological patients. METHOD The United States National Institutes of Health clinical trial registry was searched on 1 July 2013, for currently recruiting phase I, II or III clinical trials in… CONTINUE READING